Treatment Innovations

Restoring Sight: Science Corporation’s Prima System Marks a New Era for Geographic Atrophy Patients

• Treatment Innovations

Restoring Sight: Science Corporation’s Prima System Marks a New Era for Geographic Atrophy Patients

Nana Muazin July 23, 2026

In a landmark development for neuro-ophthalmology and bioelectronics, California-based Science Corporation has officially launched its Prima system...

Read More Read more about Restoring Sight: Science Corporation’s Prima System Marks a New Era for Geographic Atrophy Patients

Biopharma Industry Update: July 2026 – Clinical Milestones and Strategic Realignment

• Treatment Innovations

Biopharma Industry Update: July 2026 – Clinical Milestones and Strategic Realignment

Asro July 23, 2026

The pharmaceutical landscape underwent significant shifts this week, with major updates emerging from late-stage clinical trials, strategic...

Read More Read more about Biopharma Industry Update: July 2026 – Clinical Milestones and Strategic Realignment

The $10 Billion Gamble: Behind the Scenes of Vertex Pharmaceuticals’ Acquisition of Crinetics

• Treatment Innovations

The $10 Billion Gamble: Behind the Scenes of Vertex Pharmaceuticals’ Acquisition of Crinetics

Siti Muinah July 23, 2026

Vertex Pharmaceuticals’ recent $10 billion acquisition of Crinetics Pharmaceuticals has sent shockwaves through the biotechnology sector, triggering...

Read More Read more about The $10 Billion Gamble: Behind the Scenes of Vertex Pharmaceuticals’ Acquisition of Crinetics

A New Era in Surgery: J&J MedTech Secures FDA De Novo Clearance for OTTAVA Robotic System

• Treatment Innovations

A New Era in Surgery: J&J MedTech Secures FDA De Novo Clearance for OTTAVA Robotic System

Ali Ikhwan July 22, 2026

In a milestone development that promises to reshape the landscape of modern medicine, Johnson & Johnson (J&J)...

Read More Read more about A New Era in Surgery: J&J MedTech Secures FDA De Novo Clearance for OTTAVA Robotic System

Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

• Treatment Innovations

Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

Nila Kartika Wati July 22, 2026

In a significant advancement for genetic medicine, Arrowhead Pharmaceuticals has announced resounding success in two late-stage clinical...

Read More Read more about Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

The Silent Crisis: Why Biopharma’s Tech Transfer is Leaking Critical Knowledge

• Treatment Innovations

The Silent Crisis: Why Biopharma’s Tech Transfer is Leaking Critical Knowledge

Basiran July 22, 2026

In the high-stakes world of biopharmaceutical manufacturing, the transition of a product from the laboratory bench to...

Read More Read more about The Silent Crisis: Why Biopharma’s Tech Transfer is Leaking Critical Knowledge

Formacoat Strengthens Independent Market Position with Strategic Leadership Appointment

• Treatment Innovations

Formacoat Strengthens Independent Market Position with Strategic Leadership Appointment

Asep Darmawan July 22, 2026

Executive Summary: A New Chapter in Medical Device Coatings In a move that signals a significant shift...

Read More Read more about Formacoat Strengthens Independent Market Position with Strategic Leadership Appointment

Crystalys Therapeutics Secures $130M Series B to Propel Gout Drug Dotinurad Toward Western Markets

• Treatment Innovations

Crystalys Therapeutics Secures $130M Series B to Propel Gout Drug Dotinurad Toward Western Markets

Pevita Pearce July 22, 2026

By Jonathan Gardner | July 22, 2026 In a significant display of investor confidence, emerging biotech firm...

Read More Read more about Crystalys Therapeutics Secures $130M Series B to Propel Gout Drug Dotinurad Toward Western Markets

From Pens to Pills: The Paradigm Shift in GLP-1 Drug Development

• Treatment Innovations

From Pens to Pills: The Paradigm Shift in GLP-1 Drug Development

Jia Lissa July 22, 2026

The landscape of metabolic medicine is undergoing a seismic shift. For nearly two decades, the treatment of...

Read More Read more about From Pens to Pills: The Paradigm Shift in GLP-1 Drug Development

ARUP Laboratories Advances Multiple Myeloma Diagnostics with Cutting-Edge Spectral Flow Cytometry

• Treatment Innovations

ARUP Laboratories Advances Multiple Myeloma Diagnostics with Cutting-Edge Spectral Flow Cytometry

Raul Delapena Setiawan July 22, 2026

In a significant leap forward for hematological oncology, ARUP Laboratories has officially launched the CLARISPECT Multiple Myeloma...

Read More Read more about ARUP Laboratories Advances Multiple Myeloma Diagnostics with Cutting-Edge Spectral Flow Cytometry